Antigens for Influenza Vaccine Strains Available

Can't see this email? View it online

	Infectious Diseases
	The latest infectious diseases news from News Medical

Antigens for Influenza Vaccine Strains Available

Sino Biological offers recombinant flu antigens under its ProVir® viral antigen collection. The product line covers HA, NA, and NP proteins, from all WHO-recommended vaccine strains in 2015-2023. These antigens can be used to analyze vaccine-induced antibody response.

Find out more

New Application Note: Identifying RSV Pre- and Post-fusion Glycoprotein Conformation

Respiratory syncytial virus (RSV) is a significant contributor to infant mortality with limited prevention and treatment options. The fusion glycoprotein of RSV is considered an ideal target for vaccine R&D, which exists in pre- and post-fusion forms. Due to their different performance in inducing neutralizing antibodies, confirming RSV F protein conformation is crucial throughout vaccine development and assessment. Our application note explores protocols and technical considerations for how to identify conformational changes in the RSV protein to help ensure that your RSV F protein is structurally accurate.

Download the application note

Importance of Global Pandemic Predictions for Future Outbreaks; How prepared are we?

In this interview, we speak to Ron Gutman, Co-CEO and Co-Founder of Intrivo, about the importance of global pandemic predictions for future outbreaks.

	Studying the HIV response for pandemic preparedness Researchers assessed the impact of utilizing the human immunodeficiency virus (HIV) response in improving pandemic preparedness.

	Human immunodeficiency virus and hepatitis C virus detection using ribonucleic acid sequencing among smokers Researchers identified serological Hepatitis C virus (HCV) signatures and human immunodeficiency virus (HIV) signatures through the secondary utilization of ribonucleic acid sequencing (RNA-seq) analysis data among previous and existing smokers with or without COPD (chronic obstructive pulmonary disease).

	The trajectory of CD4+ T cell responses to mRNA vaccines in older individuals Researchers investigated how age-related T-cell defects impacted the effectiveness of mRNA-based COVID-19 vaccines.

	Researchers find that study results converge on a consistent relationship between antibody levels and protection from COVID-19 Researchers described the factors associated with protection, protection thresholds, and immunobridging in COVID-19 patients.

Website: www.news-medical.net

Email: [email protected]

Telephone: +44 (0)161 457 7150

AZoNetwork UK Ltd.
NEO, 4th Floor
9 Charlotte Street, Manchester
M1 4ET, UK

Why did you receive this email?
You recently requested related information from us and asked to be notified of additional information.

Not interested anymore?
Unsubscribe or
Update Your Newsletter Subscriptions